Influence of plasma aldosterone on left ventricular geometry and diastolic function in treated essential hypertension

Hypertension Research

Volumn 25, Issue 1, 2002, Pages 49-56

  Iwashima, Yoshio ^a   Horio, Takeshi ^a   Kuroda, Setsuko ^a   Takishita, Shuichi ^a   Kawano, Yuhei ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Aldosterone; Diastole; Hypertension; Structure; Ventricles

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD FLOW VELOCITY; CONTROLLED STUDY; CORRELATION FUNCTION; DIASTOLE; DIET THERAPY; DOPPLER ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART ATRIUM; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HEART MUSCLE FIBROSIS; HISTOLOGY; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ALDOSTERONE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; VENTRICULAR FUNCTION, LEFT;

EID: 0036188891     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.25.49     Document Type: Article

References (44)

1. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
2. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension
3. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension
4. Prognosis of left ventricular geometric patterns in the Framingham Heart Study
5. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy
6. The multifactorial role of catecholamines in hypertensive cardiac hypertrophy
7. Cardiac hypertrophy: Mechanical, neural, and endocrine dependence
8. The cardiac renin-angiotensin system: An appraisal of present experimental and clinical evidence
9. Does the renin-angiotensin-aldosterone system modify cardiac structure and function in essential hypertension?
10. Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension
11. Influence of humoral and neurohormonal factors on cardiovascular hypertrophy in untreated essential hypertensives
12. "Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: Implications for therapy
13. Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy
14. Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension
15. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system
16. The regression of left ventricular hypertrophy by imidapril and the reduction of serum procollagen type III amino-terminal peptide in hypertensive patients
17. Mineralocorticoids, hypertension, and cardiac fibrosis
18. Aldosterone and myocardial fibrosis in heart failure
19. Comparison of changes in cardiac structure after treatment in secondary hypertension
20. Left ventricular systolic and diastolic function and mass before and after antihypertensive treatment in patients with essential hypertension
21. Echocardiographic determination of left ventricular mass in man; anatomic validation of the method
22. Detection of left ventricular hypertrophy by M-mode echocardiography: Anatomic validation, standardization, and comparison to other methods
23. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma
24. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography
25. Abnormal left ventricular filling: An early finding in mild to moderate systemic hypertension
26. Left ventricular diastolic function in hypertension: Relation to left ventricular mass and systolic function
27. Echocardiographic assessment of left ventricular diastolic performance in hypertensive subjects: Correlation with changes in left ventricular mass
28. Myocardial hypertrophy and left ventricular diastolic function in hypertensive patients: An echo Doppler evaluation
29. Correlations between M-mode markers of left ventricular hypertrophy and radionuclide angiographic indices of left ventricular diastolic function in mild to moderate hypertension
30. Left ventricular hypertrophy and geometry in a population sample of elderly males
31. Echocardiographic evaluation of cardiac structure and function in elderly subjects with isolated systolic hypertension
32. Influence of the arterial blood pressure and nonhemodynamic factors on left ventricular hypertrophy in moderate essential hypertension
33. Left ventricular hypertrophy in asymptomatic essential hypertension: I9ts relationship with aldosterone and the increase in sodium-proton exchanger activity
34. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension
35. Left ventricular structural characteristics in unilateral renovascular hypertension and primary aldosteronism
36. Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension
37. Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension
38. Biological determinants of aldosterone-induced cardiac fibrosis in rats
39. Impaired diastolic function and coronary reserve in genetic hypertension
40. Opposite associations of circulating aldosterone and atrial natriuretic peptide with left ventricular diastolic function in essential hypertension
41. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression
42. Increase in plasma aldosterone during prolonged captopril treatment
43. Plasma aldosterone concentrations are not related to the degree of angiotensin-converting enzyme inhibition in essential hypertensive patients
44. The effect of spironolactone on morbidity and mortality in patients with severe heart failure